Wim is an EU regulatory partner who focuses on the life sciences sector.
Wim helps pharmaceutical, medical device, cosmetics, and food companies navigate the regulatory process in Europe throughout the life cycle of their products – from planning and development to approval and marketing, and through to enforcement and ongoing compliance. His work has been recognised by The Legal 500 in its 2024 list of notable EU Regulatory: Pharma, Medical Devices, and Biotech practices.
This includes advising clients on a broad range of regulatory issues, such as regulatory pathways, product classification, marketing authorisations, CE marking, clinical trials, product, GxP/QMS requirements, internal compliance processes and procedures, advertising and promotion, HCP/HCO interactions (including fraud and abuse), market access, adverse event reporting and recalls, and digital health. He also assists clients with regulatory due diligence evaluations regarding the compliance status of acquisition targets in the life sciences sector, as well as post-acquisition integration.
He frequently works with Reed Smith’s U.S. FDA team to provide equivalent advice on EU regulations to the firm’s clients in international matters.
As a natural corollary of his regulatory practice, Wim has developed substantial experience in drafting and negotiating industry-specific agreements, including contract manufacturing, development and commercialisation, supply, quality and pharmacovigilance, distribution, and other related agreements (e.g., CTA, CRO, MSA, MTA, and API).
Wim has represented clients before EU and national regulatory agencies in investigations and enforcement matters. This work also includes carrying out internal audits, developing corporate compliance programmes, and assisting with supply chain and product liability claims.
In addition to his life sciences practice, Wim also advises more generally on EU market access matters in multiple industries, such as consumer products, industrial machinery, e-commerce, technology, and manufacturing, and he is a core member of the firm’s Retail and Consumer Goods Group. This work includes counselling on product standards (safety, health, and environment), regulatory compliance approvals (including CE marking, packaging, and labelling), cross-sectoral requirements (e.g., materials and waste management, sustainability, and carbon neutrality), and internal market issues. He advises on the legal, practical, and procedural aspects of EU law-making, engaging with EU institutions to anticipate, understand, and influence policy and the legislative and regulatory developments that impact clients’ businesses.
Wim has been quoted by The Wall Street Journal, The Economist, Politico, PaRR, Food Quality and Safety, New Europe Online, Bloomberg Businessweek, and Dow Jones Newswires.
Experience
Representative matters
Advised a diabetes device manufacturer with overall compliance of its glucose monitoring system under medical device regulations, as well as other issues such as:
- justified collection and use of patient data under medical device regulations versus data protection;
- its collaboration agreement with a pharmaceutical company in terms of quality/safety/post market surveillance requirements as well as patient data sharing;
- allegations of non-compliance with vigilance reporting duties;
- misuse of its system by a third party for a nutrition coaching program; and
- data sharing collaboration and informed consent requirements.
Medical devices
Advised a diabetes device manufacturer with overall compliance of its glucose monitoring system under medical device regulations, as well as other issues such as:
- justified collection and use of patient data under medical device regulations versus data protection;
- its collaboration agreement with a pharmaceutical company in terms of quality/safety/post market surveillance requirements as well as patient data sharing;
- allegations of non-compliance with vigilance reporting duties;
- misuse of its system by a third party for a nutrition coaching program; and
- data sharing collaboration and informed consent requirements.
Pharmaceutical and biotechnology
Health care, cosmetics, and food
EU market access and Product Compliance
Advised a global e-commerce company on various internal market issues such as:
- Product compliance and liability issues under EU market surveillance regulation and General Product Safety Regulation;
- Compatibility under EU law of the proposed French reparability index and prepared submission to the European Commission
- Compatibility of the French medialaw reforms under EU law, in particular the EU copyright directive.
Credentials
Education
- University of Edinburgh, 2002, LL.M.
- KU Leuven, 2001, LL.B.
Professional admissions & qualifications
- Brussels
Court admissions
- EU Court of Justice and General Court
Professional affiliations
- Visiting lecturer, King’s College London (UK), 2012-2019